
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is expected to continue its upward trajectory due to its strong financial performance, driven by their unique and effective fertility benefits solutions. With a growing customer base, expanding into new markets, and prioritizing patient experience and partnerships with health plans, the company is well-positioned for long-term success. Its sustained growth, profitability, and superior clinical outcomes give confidence in its potential for continued growth and make it a promising investment opportunity.
Bears say
Progyny is facing increased competition and a shift in purchasing decisions towards measurable outcomes and ROI rather than marketing narratives. Additionally, the company's recent investments in technology infrastructure have impacted margins and may not immediately lead to increased profitability. The company is also facing pressure to maintain high conversion rates and may not be able to sustain its recent levels. These factors contribute to our negative outlook on PGNY's stock.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares